Company Overview - Turn Therapeutics Inc. is a clinical-stage biotechnology company focused on developing therapies for dermatology, advanced wound care, and infectious diseases [3] - The company has received three FDA clearances for its proprietary formulations and is advancing late-stage clinical programs in eczema and onychomycosis [3] - Turn Therapeutics is also engaged in global health initiatives, particularly in thermostable vaccine delivery aimed at underserved areas worldwide [3] Leadership and Public Engagement - CEO Brad Burnam emphasized the importance of restoring public trust in health authorities during a conversation with Dr. Robert Redfield, former CDC Director [2] - The discussion highlighted the obligation of companies and public health authorities to communicate fact-based science to the public [2] - Dr. Redfield is recognized for his advocacy of science-based decision-making and has made significant contributions to HIV research [2]
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.